$AVXL News Article - Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from ANAVEX 2-73-PDD-001 Parkinson's Disease Dementia Study at AD/PD(TM) 2022 International Conference
https://marketwirenews.com/news-releases/anav...71080.html